Dissertations / Theses on the topic 'Human endogenous retroviruse'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Human endogenous retroviruse.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
DOLCI, MARIA. "UNRAVELING THE ROLE OF THE HUMAN ENDOGENOUS RETROVIRUSES IN THE PATHOGENESIS OF COLON CANCER." Doctoral thesis, Università degli Studi di Milano, 2020. http://hdl.handle.net/2434/703397.
Full textKatzourakis, Aris. "The evolution of human endogenous retroviruses." Thesis, Imperial College London, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.497642.
Full textMuir, Alison. "Placental expression of human endogenous retroviruses." Thesis, University of Cambridge, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.616115.
Full textAkleh, Rana Elias. "Developing a Single-Cycle Infectious System to Study an ERV-K Retroviral Envelope." Thesis, Boston College, 2017. http://hdl.handle.net/2345/bc-ir:107695.
Full textEndogenous Retroviruses (ERVs) are “fossilized” retroviruses of a once exogenous retrovirus located in the genome of extant vertebrates. Retroviral infection results in a provirus integration into the host genome. An infection of a germline cell could lead to the provirus potentially being inherited by the offspring of the infected individual. Once in the genome, the provirus becomes subject to evolutionary processes and can become either lost or fixed in a population, remaining as “fossils” long after the exogenous retrovirus has gone extinct23. Notably, 8% of the human genome consists of ERVs30. Human Endogenous Retrovirus Type K (HERV-K)(HML-2) family is of particular interest. HERV-K integrations are as old as 30-35 million years, endogenizing before the separation of humans and Old World Monkeys. However, there are human specific insertions, some as young as 150,000 – 250,000 years, making them the youngest insertion in the human genome. There are over 90 insertions in the human genome; the bulk is shared by all humans44,47. Transcripts of HERV-K genes are upregulated in multiple cancer and tumor cell lines 14,39,46, as well as in HIV-1 infected patients 7,11,29. Just as there are human specific insertions of ERV-K, there are also Old World Monkey specific insertions44. I have identified an intact endogenous retroviral envelope open reading frame on chromosome 12 of the rhesus macaque genome. This viral envelope-encoding sequence, which I refer to as rhERV-K env, retains all the canonical features of a retroviral Env protein. An alignment between rhERV-K env and a consensus sequence of HERV-K, HERV-Kcon env, shows a 70% amino acid sequence identity. For experimental purposes, reconstructed HERV-K envelopes have been incorporated into virions of Human Immunodeficiency virus (HIV-1)19,26,49, Murine Leukemia Virus (MLV)12, and Vesicular stomatitis Virus (VSV)26,41,49. While these approaches have illuminated some aspects of HERV-K Env-mediated entry, to date a cell-surface receptor has not been identified for any ERV-K Env. This could be due to its low infectivity levels12,26,49, its seemingly broad cell tropism limiting identification of null cell lines26,49, or possibly the HERV-K consensus reconstructions are not an accurate representation of the progenitor HERV-K virus. I am interested in understanding how the ERV-K retrovirus accessed the human germline (some 150,000 – 250,000 years ago). To do this, I focused specifically on the envelope proteins of HERV-K and rhERV-K, with the goal of analyzing the ERV-K entry process. The identification and inclusion of rhERV-K Env in this study is meant to circumvent the possibility that the previously described consensus reconstructions of human HERV-K Env are not representative, and may also provide a means to compare the endogenization process in the human/ape and old-world monkey lineages. I focused on developing two systems for single-cycle infection, one based on Mason-Pfizer Monkey Virus (MPMV) (which has not been done before), and a second based on MLV, which has previously been reported on. MPMV, like HERV-K, is a betaretrovirus, and I reasoned that possibly using a betaretrovirus would overcome some of the low-infectivity issues associated with prior attempts using HIV and MLV. To develop a system for examining function of the ERV-K Env proteins, I addressed 3 issues: 1. Are the HERV-K Env and rhERV-K Env proteins expressed and properly processed? 2. Can they be incorporated into virions of a heterologous virus? 3. Are ERV-K pseudotyped virions infectious? I have answered these questions in the following thesis
Thesis (MS) — Boston College, 2017
Submitted to: Boston College. Graduate School of Arts and Sciences
Discipline: Biology
Singh, Manvendra [Verfasser]. "Human endogenous retroviruses aid embryonic development / Manvendra Singh." Berlin : Freie Universität Berlin, 2019. http://d-nb.info/1181097703/34.
Full textForrest, Graham Robert. "Human endogenous retrovirus 3 : evolutionary conservation and function." Thesis, Imperial College London, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312093.
Full textHu, Lijuan. "Endogenous Retroviral RNA Expression in Humans." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Universitetsbiblioteket [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8213.
Full textKowalski, Paul Edward. "Novel genetic effects of a human endogenous retrovirus insertion." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp02/NQ34571.pdf.
Full textSingh, Sarita. "Human endogenous retrovirus K gene expression in cutaneous melanoma." Thesis, Imperial College London, 2012. http://hdl.handle.net/10044/1/10118.
Full textAl-Shamarti, Ibtihal I. A. "Epigenetic dynamics of Human Endogenous Retroviruses (HERVs) in human cancer cell lines." Thesis, University of Leicester, 2018. http://hdl.handle.net/2381/42767.
Full textPatience, Clive. "Studies of endogenous retrovirus expression in human and pig cells." Thesis, Institute of Cancer Research (University Of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300308.
Full textAndersson, Ann-Catrin. "Studies on Human Endogenous Retroviruses (HERVs) with Special Focus on ERV3." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2002. http://publications.uu.se/theses/91-554-5342-2/.
Full textZsíros, József. "Detection and analysis of HERV-K related endogenous retroviruses in the human genome." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/81502.
Full textMoore, Richard. "The study of retroviral sequences in human leukaemia." Thesis, Open University, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367996.
Full textVARGIU, LAURA. "Characterization of Human Endogenous Retrovirus sequences identifed in the human genome using the RetroTector software." Doctoral thesis, Università degli Studi di Cagliari, 2014. http://hdl.handle.net/11584/266463.
Full textTie, Christopher Hieng Chie. "Epigenetic control of endogenous retroviruses and their immune recognition in differentiated human cells." Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/10038410/.
Full textYi, Joo-Mi. "Molecular genetic analysis of human endogenous retroviruses (HERVs) in primates : Expression, evolution, and phylogeny." 京都大学 (Kyoto University), 2004. http://hdl.handle.net/2433/145477.
Full textRigogliuso, Giuseppe [Verfasser]. "Analyses of human endogenous retrovirus-encoded proteins with potential relevance for human biology and diseases / Giuseppe Rigogliuso." Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2020. http://d-nb.info/122534915X/34.
Full textAL, DOSSARY REEM. "Activation of human endogenous retrovirus K and cellular modifications in human melanoma cell lines: gene expression analysis." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2010. http://hdl.handle.net/2108/1389.
Full textFreimanis, Graham L. "The detection and role of human endogenous retrovirus K (HML-2) in rheumatoid arthritis." Thesis, University of Wolverhampton, 2008. http://hdl.handle.net/2436/41777.
Full textMacFarlane, Catriona. "The genomic distribution of Human Endogenous Retroviruses (HERV-K) and the evolution of the primates." Thesis, University of Edinburgh, 2005. http://hdl.handle.net/1842/24866.
Full textEjtehadi, Hora Davari. "Study of human endogenous retroviruses HERV-K10 and ERV3 in cell lines and rheumatoid arthritis." Thesis, University of Wolverhampton, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414802.
Full textHolder, Elizabeth. "The role of placental human endogenous retroviruses and shed microvesicles on the maternal immune system." Thesis, University of Manchester, 2011. https://www.research.manchester.ac.uk/portal/en/theses/the-role-of-placental-human-endogenous-retroviruses-and-shed-microvesicles-on-the-maternal-immune-system(a4dfe0ac-c938-4768-99d6-7f132c5aecf9).html.
Full textMorandi, Elena. "The viral hypothesis in multiple sclerosis : role of Epstein-Barr virus and human endogenous retroviruses." Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/45125/.
Full textDENBOBA, AYELE ARGAW. "Human Endogenous Retrovirus-K affects cellular plasticity and generation of stem-like CD133+ cells in melanoma cancer cells." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2013. http://hdl.handle.net/2108/203227.
Full textPISANO, MARIA PAOLA. "Characterization of the Human Endogenous Retrovirus (HERV) HML-6 group and identification of HERV differential expression in immunity." Doctoral thesis, Università degli Studi di Cagliari, 2020. http://hdl.handle.net/11584/294812.
Full textSilva, Danielle Ferreira e. "Avaliação da expressão de retrovírus endógenos humanos em pacientes com neuroblastoma." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/42/42132/tde-08092016-133959/.
Full textNeuroblastoma represents the most common solid tumor as well as the most lethal form of tumor in children. Several families of human endogenous retroviruses (HERV) are present in human genome in different integrity levels, and they are reactivated under different circumstances. HERV activity has been linked to diseases such as cancer, autoimmune diseases and even with the infection by exogenous viruses. The main goal of this project was to evaluate the expression of endogenous retroviruses families H (HH), W (HW) and K (HK) in patients diagnosed with neuroblastoma. Tumor samples and control samples were subjected to RNA extraction and a single round in-house RT-PCR. HERVs amplicons were next generation sequenced to access the specific origin of transcripts. Overall, 43 HH loci and 14 HW loci were differentially expressed between groups and, 202 HK loci was detected. Taken together, HERV expression analysis and genetic and epigenetic context of neuroblastoma provided several hypotheses about regulation of HERV expression in this type of tumor. The global hypomethylation of tumoral tissue may have a role in genes expression and retrotransposons reactivation, which may be the main reason for HERV expression in this context.
Fimereli, Danai. "Computational analyses of gene fusions, viruses and parasitic genomic elements in breast cancer." Doctoral thesis, Universite Libre de Bruxelles, 2018. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/263609.
Full textDoctorat en Sciences biomédicales et pharmaceutiques (Médecine)
info:eu-repo/semantics/nonPublished
CADEDDU, MARTA. "Characterization of the human endogenous retrovirus HERV-‐K(HML-‐6) and HERV-‐K(HML-‐10) sequences and analysis of their expression." Doctoral thesis, Università degli Studi di Cagliari, 2016. http://hdl.handle.net/11584/266897.
Full textAl-shehabi, Hussein [Verfasser]. "The role of human SAMHD1 in restricting porcine endogenous retroviruses (PERVs) and the innate immune response to PERV infection in human primary immune cells / Hussein Ali Nasser Al-shehabi." Berlin : Freie Universität Berlin, 2020. http://d-nb.info/1215099088/34.
Full textAl-shehabi, Hussein Ali Nasser [Verfasser]. "The role of human SAMHD1 in restricting porcine endogenous retroviruses (PERVs) and the innate immune response to PERV infection in human primary immune cells / Hussein Ali Nasser Al-shehabi." Berlin : Freie Universität Berlin, 2020. http://d-nb.info/1215099088/34.
Full textMORONI, GABRIELLA. "Human melanoma phenotypes and HERV-K expression." Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2008. http://hdl.handle.net/2108/696.
Full textMelanoma development is a multistep process arising from a series of genetic and epigenetic events that includes cell transformation and the change in the interactions between the transformed cells and the host. Despite the clearly defined sequential stages involved in the progression from melanocytes to malignant melanoma, little is known about the events leading to melanoma insurgence and progression. Growing evidence show that the activation of endogenous retroviral sequences might be involved in transformation of melanocytes as well as in the increased ability of melanoma cells to escape immune surveillance. In this study we show that melanoma cells in vitro spontaneusly gave rise to a more malignant non-adherent phenotype, characterized by an increased proliferative potential and a decreased expression of both HLA class I molecules and Melan-A/MART-1 antigen, features that typically characterize highly malignant cells. These phenotypic and functional modifications are accompanied by the activation of human endogenous retrovirus-K (HERV-K) expression and a massive production of viral-like particles, suggesting a tight correlation between HERV replication and melanoma progression.
GRANDI, NICOLE. "Identification and characterization of Type W Human Endogenous Retroviruses (HERV-W) in humans and comparative analysis of the group in non-human primates: new insights on HERV-W diffusion in Simiiformes and analysis of evolutionarily highly related sequences in New World Monkeys." Doctoral thesis, Università degli Studi di Cagliari, 2017. http://hdl.handle.net/11584/249598.
Full textBaker, Bradley J. "The evolutionarily related major histocompatibility complex and CD1 : evolution of an endogenous retrovirus responsible for a polymorphism in human C4 and the biochemical characterizations of CD1A and E /." The Ohio State University, 1998. http://rave.ohiolink.edu/etdc/view?acc_num=osu148794983620512.
Full textMontgiraud, Cécile. "Définition de puces à ADN dédiées aux rétrovirus endogènes humains : applications à l’analyse du contrôle épigénétique et transcriptionnel." Thesis, Lyon 1, 2011. http://www.theses.fr/2011LYO10195.
Full textEndogenous Retroviruses (ERVs) are inherited part of the Eukaryotic genomes, and represent about 400,000 loci in the Human genome divided in distinct families. The majority of HERVs (Human ERV) are mainly silent in most physiological contexts excepted in placenta, whereas a significant expression is observed in pathological contexts such as cancers. It is difficult to understand HERV (de)regulation mechanisms and their implication in physio-pathological contexts, as there is no criteria defining transcriptional active promoters HERV long terminal repeats (LTRs) among all these regulatory élements. We developed two versions of highdensity DNA microarray to specifically detect LTR reactivated in cancers and try to understand transcription mechanism of HERV. With the first version of HERV-microarray, we identified six HERV-W loci over-expressed in testicular cancer, including the domesticated ERVWE1 locus which produces an envelope protein dubbed Syncytin-1 associated with placenta development. The analysis of DNA from tumoral versus normal tissue reveals that hypomethylation of U3 promoters in tumors is a prerequisite of HERV activation. The second version of HERV-microarray was used to identify prognosis biomarkers in non small cell lung cancer. This study identified HERV reactivation in some samples and highlighted difficulties of such approach due to inter-individuals disparities
Gimenez, Juliette. "Implication de la méthylation dans le contrôle de l'expression de rétrovirus endogènes humains en contextes physiologiques et pathologiques." Thesis, Lyon 1, 2009. http://www.theses.fr/2009LYO10222.
Full textEndogenous retroviruses are constitutive elements of most eukaryotic genomes. They represent about 400,000 loci in the human genome. HERVs are divided into distinct families on the basis of phylogenetic identities but are highly heterogeneous in structures. Their activity can be detrimental, neutral, or beneficial to the host. Majority of HERVs seems silent in somatic cells. Still, some are highly expressed in physiological contexts. Besides, a significant expression of HERVs is frequently observed in pathological contexts such as cancers. Silencing of repeated elements is supposed to occur mainly through DNA methylation. We were therefore interested by the implication of HERV regulatory region (LTR) methylation in the control of their expression. First, this study identified locus and tissues –specific HERV LTR methylation in physiological context, worth noting particular methylation modalities that control domesticated HERVs placental expression. Second, we could determine a change in intra-family LTR methylation modalities in testicular tumors leading to the autonomous reactivation of six HERV-W loci, among which a domesticated one. Thus methylation clearly influences HERVs expression, but under modalities varying upon the loci and the contexts
Schönfeld, Regine Margarete. "Generation of Transgenic Mice to Evaluate Promoter Activity and Specificity of Two Human Endogenous Retrovirus Long Terminal Repeats = Untersuchungen zur Promotor-Aktivität und -Spezifität von zwei Long Terminal Repeats humaner endogener Retroviren in transgenen Mäusen." Diss., lmu, 2003. http://nbn-resolving.de/urn:nbn:de:bvb:19-9017.
Full textBEYER, ULRIKE [Verfasser], Matthias [Akademischer Betreuer] Dobbelstein, Ralf [Akademischer Betreuer] Ficner, and Thomas [Akademischer Betreuer] Pieler. "Novel proapoptotic p63 isoforms are driven by an endogenous retrovirus in the male germ line of humans and great apes, likely increasing genome stability / Ulrike Beyer. Gutachter: Ralf Ficner ; Thomas Pieler ; Matthias Dobbelstein. Betreuer: Matthias Dobbelstein." Göttingen : Niedersächsische Staats- und Universitätsbibliothek Göttingen, 2011. http://d-nb.info/1043068910/34.
Full textPerot, Philippe. "Étude du transcriptome des rétrovirus endogènes humains et implications fonctionnelles : applications à la recherche de marqueurs diagnostiques de cancers." Thesis, Lyon 1, 2012. http://www.theses.fr/2012LYO10228/document.
Full textThe human genome contains around 200,000 endogenous retroviral sequences (HERV) integrated during the evolution and which are nowadays organized into complex multicopy families, globally repressed by epigenetic control. The study of the HERV transcriptome at the locus level is complicated by phylogenetic similarities within one family and by the profusion of integration sites, two inherent characteristics of transposable elements. In this work, we used a method aiming to optimally characterize individual loci associated with 25 mer probes. A custom microarray dedicated to more than 5,500 HERV sequences and allowing a functional interpretation of the LTRs expression was used on a panel of normal and tumor tissues. We therefore identified 1,718 active HERV sequences, including 326 promoter LTRs and 209 polyA LTRs. The study of the genomic environment has highlighted an approximately 8 kb zone upstream of promoter LTRs characterized by a drastic reduction in sense cellular genes. We also showed that the HERV transcriptome follows tropism rules, is sensitive to the state of cell differentiation and, unexpectedly, seems not to correlate with the age of the families. In a first attempt to use the HERV repertoire in clinical, we sought to identify new markers of prostate cancer from urine samples. This goal was pursued by conducting a pilot study on 45 patients
Mommert, Marine. "Modulation de l'expression des rétrovirus endogènes humains dans des contextes d'inflammation et d'immunosuppression." Thesis, Lyon, 2018. http://www.theses.fr/2018LYSEN044.
Full textSepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection.The heterogeneity of the disease present a major clinical challenge with regard to the therapeutic coverage,and this day the proposed markers are not enough to stratify patients. The human endogenous retrovirus(HERV) could be relevant markers, considering the immunosuppressives properties of their envelopes andtheir expression in inflammatory and autoimmune disease. The aim of this thesis is to know to what extentthe HERVs are expressed and modulated, in inflammatory and immunocompromised contexts. For this, weused a high density DNA chip allowing (i) the transcription analysis of 363,689 HERV and 1500 genes,and (ii) a functional reading of LTRs activities. The HERVs expression was objectified (i) in endotoxintolerance ex vivo model in peripheral blood mononuclear cells (PBMCs) of healthy volunteers and (ii) inwhole blood of healthy volunteers and septic shock patients, stratified or not according to immunity state.(1) Of 5,6% at 6,9% of HERVs are expressed in the blood compartment and around 20% of LTRs have apromoter or polyA function, both functions being mutually exclusive. (2) The HERV transcriptome ismodulated in ex vivo endotoxin tolerance model letting appear two higher transcriptional phenotypes. Theexpression of some HERVs loci are correlated of the immunity state of the septic shock patients. Theevaluation of molecular signature in validation cohort, allowed to separate in two patients groupspresenting different severity criteria, suggesting HERV/MaLR as biomarkers of stratification. (3) The coexpressedanalysis of genes and HERVs allowed to integrate these within signaling pathways associated atthe host immune response and to provide functional hypothesis
Tabone, Olivier. "Rétrovirus endogènes humains et réponse immunitaire de l’hôte suite à une agression inflammatoire." Thesis, Lyon, 2019. http://www.theses.fr/2019LYSE1015.
Full textFollowing inflammatory injury, like a septic shock, severe burn or important trauma, the immune system responds by a massive modulation of its transcriptome in the blood. We propose to explore another repertoire than gene expression and to focus on repeated elements, especially on HERVs. They represent more than 8% of the human genome. HERVs are expressed in similar settings (cancer or auto-immune diseases) and impact immune response. In this project, we describe and aim to better understand the HERV contribution in host immune response, following inflammatory aggression. To bring elements of response, we developed specifically dedicated tools to describe the HERVome, either at genomic or transcriptomic level. We show HERVs are expressed in blood in these settings, modulated in patients and could play a role on nearby gene expression. We also evaluate the polymorphism of presence of HERV loci on more than two thousands individuals, grouped into human populations. We show an important HERV polymorphism, that it is population-specific, and that some loci are absent in the majority of the analyzed genomes.Finally, with different approaches, we identify associations between immune-response genes and HERVs, suggesting these elements can play a role in host immune response following inflammatory aggressions
Reynaud, Joséphine. "Développement d'un modèle murin transgénique d'infection par l'herpèsvirus 6A et étude des mécanismes d'induction de la neuroinflammation." Phd thesis, Ecole normale supérieure de lyon - ENS LYON, 2013. http://tel.archives-ouvertes.fr/tel-00998378.
Full textSimmons, William Minnow. "Contributions of viral and cellular gene products to the pathogenesis and prognosis of aggressive lymphomas." Thesis, University of Wolverhampton, 2016. http://hdl.handle.net/2436/609034.
Full textGrosjean, Iris. "SQSTM1, une protéine de plateforme à la croisée de la réponse aux dommages à l’ADN et de la réponse à l’immunothérapie dans le cancer : rôles des rétrovirus endogènes." Electronic Thesis or Diss., Université Côte d'Azur, 2020. http://www.theses.fr/2020COAZ6037.
Full textNon-small cell lung cancer (NSCLC) is the deadliest cancer in the world, due to acquired resistance to genotoxic chemotherapy and radiotherapy (DNA-damaging agents, named DDAs hereafter) and targeted therapies. Immunotherapy (including immune checkpoint inhibitors (ICIs)) is a real revolution in patient care. This strategy has indeed had a positive impact, turning into treatable advanced cancers without "actionable" targets that were considered incurable. Survival at 5-year has increased from 5% with conventional treatment to 20% with immunotherapies and up to 50/60% for melanoma and lung cancer with therapies combining ICIs and DDAs. The current challenge in clinical trials is to develop combined therapeutic strategies that increase efficacy while limiting resistance to different treatments. Elucidating resistance mechanisms is essential to propose new robust predictive biomarkers and new therapeutic approaches to improve the efficacy of ICIs.We have hypothesized that resistance to DDAs and ICIs is mediated by intrinsic tumor mechanisms, some of which may be shared. Thus, we have studied the action of DDAs and their molecular consequences that lead to immune evasion. Through three complementary approaches (in silico, in vivo on patient cohorts and in vitro), we identify the p62/SQSTM1 scaffold protein as a key molecular mediator capable of predicting and controlling sensibility to DDAs and ICIs. We report for the first time that SQSTM1 causes a "HOT" tumor immune profile, while downregulating DNA repair mechanisms. In addition, SQSTM1 is essential for the DDAs-induced reactivation of human endogenous retroviruses (hERVs). Downstream, hERVs induce an innate antiviral response, resulting in the expression of interferons, MHC-I and PD-L1, leading to tumor immune evasion.In conclusion, i) we propose SQSTM1 as a predictive biomarker for selecting patients who may benefit from ICI plus DDA combination strategies, and ii) we highlight a biological rationale for the efficacy of such strategies in refractory lung cancer, aimed at promoting their use and thus improving the prognosis of NSCLC
Schjenken, John Even. "Human endogenous retroviruses and immune tolerance in pregnancy." Thesis, 2011. http://hdl.handle.net/1959.13/923742.
Full textThe human placenta expresses endogenous retroviral envelope proteins which have been postulated to play an important role in the physiology of pregnancy. Of these, syncytin-1 and syncytin-2 are highly expressed in the syncytiotrophoblast and cytotrophoblast respectively and are thought to be key factors in the regulation of syncytialisation due to their fusiogenic properties. In addition to their role in cell fusion, it has also been speculated that syncytin-1 and syncytin-2 may have a role in maternal immune tolerance due to the presence of the highly conserved immunosuppressive domain (ISD) within its sequence. However, no studies are yet to confirm this putative role. Another factor which has been speculated to have a role in maternal immune tolerance is Corticotropin Releasing Hormone (CRH) which has been shown to promote implantation and the maintenance of early pregnancy via the regulation of FasL. Interestingly, both syncytin-1 and FasL have been identified in immunosuppressive placental exosomes. Since CRH stimulates cyclic AMP (cAMP) production and syncytin-1, syncytin-2 and FasL are all stimulated by the cAMP second messenger pathway, it was hypothesised that syncytin-1 and syncytin-2 may be regulated by CRH. Further, it was hypothesised that syncytin-1 may contribute to the modulation of the maternal immune environment during pregnancy. To examine the regulation of syncytin-1 and syncytin-2 by CRH, a combined nucleic acid and protein extraction procedure was developed using column based nucleic acid extraction kits. Using 2D buffer, proteins extracted using this method were shown to have a comparable protein profile to conventionally extracted proteins. This method was then used to examine RNA and protein levels in CRH treated BeWo cells. Following CRH treatment of BeWo cells, a significant upregulation of syncytin-1, syncytin-2 and FasL mRNA was observed. CRH also increased the production of the syncytin-1 precursor in an exosomal fraction. To examine the immunosuppressive properties of syncytin-1, the recombinant ectodomains of human and mouse syncytins were produced and purified using a combination of affinity chromatography and gel filtration. The immunosuppressive properties of the syncytin-1 recombinant ectodomain were then tested using a whole blood culture model stimulated with LPS or PHA. Syncytin-1 recombinant ectodomain at a concentration of 1µM inhibited the production of TNF-α by 50% and CXCL10 by 65% in whole blood cultures following maximal stimulation with LPS. Syncytin-1 recombinant ectodomain also inhibited the production of IFN-γ by 30% in PHA stimulated PBMC. These studies demonstrate for the first time that syncytin-1 has immunosuppressive properties. Further, these studies show that CRH has a role in the stimulation of syncytin-1 and its subsequent sorting into exosomes. Circulating placental exosomes containing syncytin-1 and other immunosuppressive factors including FasL may interact with maternal immune cells to prevent an immune response against the fetal-placental unit. This is a novel mechanism that may contribute to our understanding of how a genetically different fetus can be tolerated by the mother during pregnancy.
Lung, Chao Meng, and 趙孟隆. "Functional study of human endogenous retrovirus HERV-Ia LTR-like hancer." Thesis, 1993. http://ndltd.ncl.edu.tw/handle/84198401235766840404.
Full textGoodchild, Nancy L. "The impact of endogenous retrovirus-like sequences on the human genome." Thesis, 1993. http://hdl.handle.net/2429/6917.
Full textChang, Nien-Tzu, and 張念慈. "Study on the Transcriptional Regulation of Human Endogenous Retroviruses and their Pathogenic Potentials." Thesis, 2008. http://ndltd.ncl.edu.tw/handle/55626230751393070845.
Full text國防醫學院
生命科學研究所
96
Endogenous retroviruses have a wide distribution within vertebrates; they are present in multiple copies dispersed throughout the genomes of host species. Human endogenous retroviruses (HERVs) constitute about 8% of the human genome. The prevalence and maintenance of HERVs elements suggest that they may play a role in the biology of the host species. HERVs are related to retroviruses with their characteristic LTR-gag-pol-env-LTR structure, in which LTRs possess the enhancer and the promoter functions for RNA transcription, viral integration and polyadenylation. Transcriptional activation of HERVs is supposed to be potentially pathogenic for producing retroviral proteins and RNA copies to form virus particles, proceeding to retro-transposition and insertion mutagenesis, altering the expression of neighboring or distant cellular genes from the insertion sites and eventually leading to neoplastic transformation or genetic disease. In most cases, HERVs are either structurally defective or inactive due possibly to stringent negative control mechanisms. Since RNA transcripts of HERV-I in various human cancer cells were hardly detectable by Northern blots in our preliminary studies, we isolated the LTR of RTVL-Ia and constructed site-specific mutations for analysis of the promoter and enhancer functions by using chloramphenicol acetyl transferase (CAT) reporter assay. Our results showed that 5’-LTR of HERV-I possess bi-directional promoter activity and unidirectional enhancer activity. The ATAAAAA element, a TATA-like box, in 5’-LTR mainly exerts a promoter function while the CCAAT element exhibits a partial enhancer function, and these two elements in the LTR apparently provide maximum transcriptional activity. Therefore, the poor transcriptional activity of HERV-I LTR may be due to the AGTAAA segment at the presumed polyadenylation site which plays a negative regulatory role in controlling gene expression. P53 is a tumor suppressor protein, and its mutations are the most frequently reported genetic alterations in human cancers. P53 has been shown to repress or activate the transcription activity of several cellular and viral promoters, although its effect on HERVs is not known. We have found that wild type (wt) p53 can efficiently repress the transcriptional activity of HERV-I LTR presumably through the interaction of wtp53 with the TATA-binding proteins or CAAT-binding proteins. In addition, mutantp53(V143A) can more or less stimulate the transcriptional activity of HERV-I LTR. These results imply that, following p53 mutation, LTRs are likely to be activated and might aberrantly regulate their neighboring cellular genes during the tumor progression processes. To study the possible involvement of p53 in chromosomal HERV expression, we further examined the RNA transcripts of HERV-E, HERV-H, HERV-I, HERV-K and HERV-W multi-gene families in p53-null Saos-2 cells transfected with wtp53 or “hot-spot” site-specific p53 mutants. Quantitative real-time PCR analysis showed that limited RNA expression of these HERVs in Saos-2 cells were not affected by wtp53 but could be elevated by mtp53(D281G), through transient or stable transfection. 5-Azacytidine and trichostatin A, known to activate endogenous retroviruses in other animals, did not induce HERV expression in the parental Saos-2 cells or wtp53 transfectants but could additively increase HERV genes expression especially in cells stably transfected with mtp53(D281G). Our results suggest that the stringent controlled chromosomal HERV genes may be compromised by p53 mutation, especially at codon 281, in combination with epigenetic chromatin alterations, leading to the activation of potentially pathogenic retrotransposable gene functions.
Liao, Chao Ching, and 廖昭晴. "Molecular Investigation and Multiple Factors Analysis of Human Endogenous Retroviruses in Juvenile Rheumatoid Arthritis." Thesis, 2010. http://ndltd.ncl.edu.tw/handle/08613770156837071655.
Full text長庚大學
醫學生物技術暨檢驗學系
98
Human endogenous retroviruses (HERVs) represent a class of interspersed mobile repetitive elements in human genome which comprised 8% of whole human genome. HERVs have been suggested as potential etiological agents and cofactors in chronic diseases such as autoimmune diseases, particularly in rheumatic diseases. However, the exactly role of HERVs in rheumatic diseases is still unclear. This study focused on the elucidation of the role of HERVs in human genome and its associated characteristics with human autoimmune diseases, especially in juvenile rheumatoid arthritis (JRA). HERV-K is one of the most completed sequence including LTR-gag-pol-env-LTR and open reading frame in HERV family. HERV-K has potential ability to produce viral protein or even package viral particle. The aim of this study was to study copy number and gene expression of HERV-K from peripheral blood mononuclear cells between JRA patients and controls. Our hypothsis was that there could have copy number, gene expression variations, and insertional polymorphisms of HERV-K family. Besides geneneral HERV-K family study, we also focused on HERV-K10 and HERV-K18 which have been mentioned to be important in autoimmune diseases in previous studies. Real-time quantitative PCR was performed to detect HERV-K structure protein genes, gag and env, and non-structure protein gene, pol. Tradictional PCR was performed to detect HERV-K10/K18 insertional polymorphism. For HERV-K copy number study, the results showed that there was no significant difference between all JRA patients, without subgrouping, and controls. But if we looked at subgrouping results, in male samples, there was significantly decrease of HERV-K gag and pol copy number in JRA patients, particular in pauciarticular JRA. Instead of male samples, there was significantly increase of HERV-K gag copy number in female JRA patients. For insertional polymorphism study, we did not found any polymorphisms from HERV-K10 and HERV-K18 in JRA patients and controls. In gene expression level, we found that there was significantly HERV-K gag and env mRNA decrease but significantly increase of HERV-K pol mRNA expression in JRA patients, especially in male JRA samples. There was significantly increase of HERV-K10-like gag and HERV-K18-like env gene expression in JRA patients. In this study, we demonstrated the first time that HERV-K gene expression level by detecting HERV-K’s three major gene segments. Our data conclude that there was a strong association of HERV-K family copy numbers and expression difference between JRA patients and healthy controls. Our results can contribute to the elucidatation of the JRA mechnisme, but further studies need to be done.
Passos, Vânia Patrícia Mendes. "Expression and regulation of human endogenous retroviruses (HERVs) in developing and mature T cells." Master's thesis, 2015. http://hdl.handle.net/10451/20853.
Full textThe Human genome comprises almost 8% long terminal repeat (LTR)-retroelements, in which Human Endogenous Retroviruses (HERVs) are included. More than 30 HERV groups have been identified. They share a similar provirus structure with exogenous retroviruses, despite harboring many inactivating mutations. Interestingly, HERVs have been increasingly associated with cancer, autoimmunity and infectious diseases. Data on HERV expression in T cells is sparse. Here we investigated, for the first time, the expression of several HERV families during human T cell development and differentiation. HERV-K, -W, -P and -R envelope (env) expression were analyzed in purified T cell subsets from the human thymus, peripheral blood or tonsils using real time RT-PCR. In addition, Env protein expression was studied in thymic and tonsillar tissue using immunohistochemistry. We observed a similar pattern of HERV env transcriptional expression during the development and maturation of thymocytes in the thymus. HERV levels tended to be higher in mature thymocytes than in the early developmental stages, supporting their differential regulation during T cell development. Regarding the peripheral blood compartment, HERVs showed similar transcriptional levels within naïve and memory CD4 and CD8 T cells, with small inter-individual variation. Moreover, HERV expression was modulated during T follicular helper (TFH) differentiation in human tonsils. Importantly, we further confirmed Env protein production in lymphoid tissues, as HERV-K Env protein was expressed in the medullary compartment of the thymus, as well as in the T cell zone of the tonsil. Our data regarding HERV env expression profiles during T cell development and maturation prompted us to test potential pathways of HERV regulation. We demonstrated, using real time RT-PCR, that T cell receptor (TCR) stimulation and Phorbol-12-myristate-13- acetate (PMA)-Ionomycin were able to down-regulate HERV-W, -P and -R transcriptional levels in CD4SP thymocytes. Additionally, a positive correlation was found between HERV env expression and the transcriptional levels of the retroviral restriction factor deoxycytidine deaminases apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) throughout T cell development and differentiation, which was not observed for APOBEC3F. Overall, our data support a tight regulation of HERV expression during T cell development and differentiation. This appears to be particularly pertinent in the thymus, with possible implications for the process of T cell selection.
O genoma humano é composto por aproximadamente 8% de retroelementos contendo repetições terminais longas (LTRs), nos quais se incluem os Retrovírus Endógenos Humanos (HERVs). Os HERVs são sequências de ADN que se fixaram no genoma humano após uma primeira infeção da linha germinativa por um retrovírus exógeno, sendo subsequentemente transmitidos verticalmente. A sua diversidade depende das interações com o hospedeiro, no entanto somente alguns HERVs foram capazes de persistir, sofrendo mutações e deleções que resultaram na perda da capacidade de replicação. Os HERVs dividem-se em mais de 30 famílias e 3 classes, de acordo com a sua homologia a retrovírus exógenos, sendo denominados pela letra que define o ácido ribonucleico de transferência (tRNA) usado para a transcrição reversa do seu genoma. Apesar de a maioria dos HERVs estar defetivo, vários estudos demonstraram a expressão de RNA e de proteína em vários tecidos humanos e linhas celulares, e em raras situações a produção de partículas virais intactas. Pensa-se que eles persistiram no genoma humano por duas razões: exercerem funções biológicas ou devido à incapacidade de o hospedeiro os eliminar. Curiosamente, apenas a função das proteínas do invólucro (Env) do HERV-W e HERV-FRD é reconhecida. Por outro lado, o estudo dos HERVs num contexto de doença tem aumentado, uma vez que eles têm sido associados com a ocorrência de cancro, autoimunidade e doenças infeciosas. Como não podemos excluir a existência de um HERV infecioso, é importante perceber o que pode regular a sua expressão. Canonicamente, a sua transcrição depende dos seus promotores. No entanto esta pode ser igualmente ativada por fatores de transcrição celulares (i.e., NF-κB) ou proteínas virais. Posto isto, o hospedeiro desenvolveu mecanismos para controlar a sua expressão. O enzima “apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like” 3G (APOBEC3G) e outros membros da família das citidina desaminases foram descritos como fatores de restrição virais em células humanas, atuando sobre a replicação de retrovírus, tais como o HIV e alguns HERVs. Sabe-se igualmente, que a sua transcrição é reprimida por mecanismos de metilação do DNA, modificação das histonas e RNA de interferência, no entanto os estudos em humanos são limitados. A eficiência do sistema imunitário depende da resposta da imunidade inata e adaptativa para eliminar invasões patogénicas. A imunidade inata representa a primeira linha de defesa, sendo constituída pela barreira epitelial, proteínas solúveis e moléculas bioativas. Subsequentemente, a imunidade adaptativa atua pelo reconhecimento específico de antigénios. Este reconhecimento é feito usando receptores antigénicos expressos à superfície de linfócitos B e T. No entanto, para esta resposta se dar corretamente, as células B e T têm de submeter-se a vários processos de seleção e maturação. Progenitores de células T expressando CD34+ migram da medula óssea para o timo, onde irá ocorrer o desenvolvimento e maturação das células T. Os timócitos serão distinguidos de acordo com a expressão dos corecetores CD4 e CD8, em: timócitos “triple negative” CD34+ (TN CD34+, CD4-CD8-CD3-), timócitos CD4 “immature single positive” (CD4ISP, CD4+CD8-CD3-), timócitos “double positive” (DP, CD4+CD8+CD3-/+), e timócitos CD4 ou CD8 “single positive” (SP, CD4+/-CD8-/+CD3+). Durante o processo de maturação e seleção, os timócitos sofrem rearranjo do recetor de células T (TCR) β e α. Interações de baixa afinidade entre o TCRαβ de timócitos DP e péptidos do próprio complexados com antigénios no complexo major de histocompatibilidade (MHC) são selecionados positivamente. Por outro lado, a seleção negativa ocorre se esta afinidade for demasiado alta. Timócitos selecionados positivamente diferenciam-se em células T CD4SP ou CD8SP, que após maturação migram para a periferia. Na periferia, as células T “naïve” circulam através dos órgãos linfóides secundários (p.ex. amígdalas) até sofrerem ativação, processo que envolve o encontro de antigénios apresentados por células dendríticas e o sinal co-estimulator emitido pelas mesmas (CD28). Após ativação, estas células adquirem uma das funções efetoras de células T auxiliar: Th1, Th2, Th17, Th9, T folicular auxiliar ou T reguladora. Em contrapartida, as células T CD8 “naïve” diferenciam-se em citotóxicas (CTLs). Sabe-se que, 5-10% das células T CD4 e CD8 efetoras persistem como células T de memória, caracterizadas por oferecer uma maior e mais eficiente resposta após segunda exposição antigénica. A expressão dos HERVs em células T tem sido pouco estudada. Neste projeto foi investigado, pela primeira vez, a expressão de várias famílias dos HERVs durante o desenvolvimento e diferenciação de células T. A expressão do gene env do HERV-K, -W, -P e -R foram analisadas em subpopulações de células T purificadas do timo humano, sangue periférico e amígdalas, usando Real Time RT-PCR. Paralelamente, foi avaliada a expressão da proteína Env em tecido do timo e amígdalas usando imunohistoquímica (IHQ). Os resultados revelaram um padrão semelhante de expressão génica dos HERVs durante o desenvolvimento e maturação dos timócitos no timo. Os níveis transcricionais apresentaram uma tendência para serem maiores nas fases mais desenvolvidas (CD4SP e CD8SP) do que nas fases iniciais do desenvolvimento (TN CD34+ e CD4ISP), indicando que possam estar a ser distintamente regulados. Estudos de vários grupos podem explicar este padrão. Conrad e colegas identificaram a expressão no timo humano de superantigénios codificados pelo membro HERV-K18, na fase DP com o intuito de induzir a seleção negativa de timócitos CD4 Vβ7. Adicionalmente, sabe-se que o desenvolvimento de células T no timo é altamente regulado por mecanismos epigenéticos; nas fases iniciais do desenvolvimento o DNA encontra-se hipermetilado, ao passo que ao longo da maturação e seleção o DNA torna-se hipometilado. Os HERVs são reprimidos com a metilação do DNA, por isso é possível especularmos que estes mecanismos possam explicar o padrão de expressão dos HERVs no desenvolvimento dos timócitos. Relativamente à periferia, vários estudos analisaram os níveis de HERVs em células mononucleares totais do sangue periférico. Neste projeto analisamos os seus níveis em subpopulações do sangue periférico. Os HERVs revelaram níveis transcricionais similares entre células T CD4 e CD8 “naïve” e de memória, variando pouco entre os indivíduos analisados. Podemos nesse caso especular que, o processo de proliferação homeostático envolvido na manutenção das populações “naïve” e de memória não afeta a expressão dos HERVs. Adicionalmente, a atividade transcricional dos HERVs parece ser modulada nas amígdalas durante a diferenciação de células T foliculares auxiliares. Apesar do estudo dos HERVs em órgãos linfóides secundários ser inexistente, pensamos que esta modulação se deve à ativação e ação de mecanismos regulatórios que reprimem especificamente a transcrição dos diferentes HERVs durante a diferenciação celular. É importante referir que os resultados da IHQ confirmaram a expressão da proteína Env do HERV-K no timo (medula) e na amígdala (zona das células T), e apoiam os dados obtidos na análise da expressão génica. Os dados gerados durante o desenvolvimento das células T no timo, levou-nos a investigar os possíveis mecanismos de regulação da transcrição dos HERVs. Conseguimos demonstrar, usando Real Time RT-PCR, que a estimulação por via de TCR e “PMAIonomycin” foi capaz de regular negativamente a expressão do HERV-W, -P e -R em timócitos CD4SP. Adicionalmente, observamos uma correlação positiva entre os níveis transcricionais dos HERVs e do fator de restrição APOBEC3G ao longo do desenvolvimento e diferenciação de células T, mas não com o enzima APOBEC3F. Efetivamente, parece que os mecanismos que controlam os níveis dos HERVs são específicos da célula ou população celular em que eles se expressam. Em suma, os nossos resultados indicam que os HERVs são estritamente regulados durante o desenvolvimento e diferenciação das células T. Esta regulação aparenta ser mais relevante no timo, com implicações no processo de seleção das células T.